Comprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Melyssa Aronson, Christian P. Kratz et al.|Cell|2017Cited by 795
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Meredith S. Irwin, Scott Davidson et al.|Nature Cancer|2022Cited by 127
Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy SensitivityAlvaro Blanch, Meredith S. Irwin|PLoS ONE|2013Cited by 70
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Julie R. Park, Steven G. DuBois et al.|Pediatric Blood & Cancer|2018Cited by 39
Transcript signatures that predict outcome and identify targetable pathways in MYCN‐amplified neuroblastomaRobin Hallett, Meredith S. Irwin|Molecular Oncology|2016Cited by 17